Turnaround Time: 4 to 6 days
CPT Code:
  • 83993
Test Type: Kit-Based, Stool
Reference Range:

Sex
Both

Age
0-99 years <50 ug/g

Overview:

Calprotectin is a calcium-binding protein produced by neutrophils and monocytes, and it may be involved in inflammatory signaling. Elevated Calprotectin and fecal Lactoferrin levels indicate the presence of neutrophils and inflammation in the gastrointestinal (GI) mucosa. Calprotectin and Lactoferrin differentiate between irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). IBD includes autoimmune conditions such as Crohn’s disease and ulcerative colitis (UC); these conditions may become life-threatening and require lifelong treatment.

Multiple studies have shown fecal Calprotectin and Lactoferrin to be equivalent with respect to clinical sensitivity and specificity. Studies suggest that Calprotectin may correlate more closely with histological (cell microscopy) findings. Lactoferrin may correlate better to macroscopic (endoscopy) findings, and may be the better indicator of impending relapse, elevating 2-3 weeks prior to clinical symptoms. Chronic inflammation of the gastrointestinal mucosa contributes to symptoms of IBD. Chronic stress is known to contribute to symptom flare-ups and increased inflammation. Liver disease or the use of aspirin or nonsteroidal anti-inflammatory (NSAID) medications may elevate Calprotectin levels. Fecal Calprotectin levels may also be increased in newborns.

 

Performing Lab: DDINT

Collection Details:

Patient Preparation:

Collection Container/Tube
Use supplied stool collection container

Transport Container/Tube
White-capped stool transport vial (no preservatives)

Minimum Specimen Volume
Must be filled to the ""Fill To"" line on vial

Rejection Criteria
Not received cold < 5 mL stool (< 1/2 full) > 7 days from collection

Stability Information
Room temperature:
Refrigerated: 7 days
Frozen: 14 days
37°C/99°F:

Methodology
ELISA